Abstract:Background: Recombinant human basic fibroblast growth factor (rHu-bFGF) is known to stimulate proliferation in some tumor cells and to modulate tumor vascularization. Purpose: The purpose of this study was to examine the possible role of this agent in the development of tumors. The study was designed to determine the effects of modulating bFGF activity in vivo in tumor models from cell lines with different responses to bFGF and with different content and receptor levels of bFGF. Methods: Two tumor cell lines (human DLD-2 colon carcinoma and rat C6 glioma) were characterized for bFGF content and bFGF receptor levels by Western blot analysis in cultured cells and by studies of [125I]rHu-bFGF binding to sections from xenografts grown in nude mice. Tumor cell proliferation was monitored after treatment with rHu-bFGF or the DG2 or DE6 IgG monoclonal antibody to rHu-bFGF in culture and in vivo. Results: C6 cells exhibited 7800 high-affinity receptors for rHu-bFGF per cell (dissociation constant [Kd] = 46 pM), while DLD-2 cells lacked high-affinity receptors. rHu-bFGF stimulated [3H]thymidine uptake by C6 cells, but the addition of DG2 IgG prevented this stimulation; rHu-bFGF had no effect on [3H]thymidine incorporation by DLD-2 cells. C6 cells had higher levels of immunoreactive bFGF than did DLD-2 cells. The xenografts from both cell lines exhibited high-affinity [125I]rHu-bFGF binding that was concentrated on vascular-like structures. rHu-bFGF at a dosage of 0.25 mg/kg given intraperitoneally daily for 18 days caused a twofold increase in DLD-2 tumor weight but had little effect on the growth of C6 xenografts. In contrast, daily intravenous injections of DG2 IgG given to mice had no effect on DLD-2 tumor growth but reduced growth of C6 tumors by approximately 30%--a statistically significant difference. Conclusions: The addition of exogenous rHu-bFGF or of a neutralizing antibody resulted in significant alterations in tumor growth in vivo, which were specific for tumor type and bFGF characteristics. While some of these effects may be mediated by the bFGF-responsive endothelial cells of the tumor vasculature (DLD-2 colon carcinoma), others may result from inhibition of bFGF-dependent tumor cell proliferation (C6 glioma). Implications: Studies that measure tumor blood flow are necessary to confirm that these effects are mediated by changes in tumor vasculature.

Association of bovine brain-derived growth factor receptor with protein tyrosine kinase activity

Transforming growth factor activity of bovine brain-derived growth factor

Acidic fibroblast growth factor receptor purified from bovine liver is a novel protein tyrosine kinase

Enhanced Expression of the Blood-Brain Barrier GLUT1 Glucose Transporter Gene by Brain-Derived Factors

Characterization of Vascular Endothelial Growth Factor'S Effect on the Activation of Protein Kinase C, Its Isoforms, and Endothelial Cell Growth

Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells

EXPRESSING HUMAN MATURED BRAIN-DERIVED NEUROTROPHIC FACTOR GENE IN E.Coli AND DETERMINING ITS BIOACTIVITY

Distinct Transforming Growth Factor-Beta (Tgf-Beta) Receptor Subsets As Determinants of Cellular Responsiveness to Three TGF-beta Isoforms.

A novel cyclic GMP stimulated phosphodiesterase from rat brain.

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

Purification of a growth-suppressing factor for bovine artery endothelial cells from mouse lymphoma P388D1 cells

Structures of a Platelet-Derived Growth Factor/propeptide Complex and a Platelet-Derived Growth Factor/receptor Complex.

Effects of modulation of basic fibroblast growth factor on tumor growth in vivo

Partial purification and characterization of a growth factor present in goat's colostrum. Similarities with platelet-derived growth factor

The major acidic fibroblast growth factor (aFGF)-stimulated phosphoprotein from bovine liver plasma membranes has aFGF-stimulated kinase, autoadenylylation, and alkaline nucleotide phosphodiesterase activities

Growth-promoting Effect of Platelet-Derived Growth Factor on Rat Cardiac Myocytes

Regulation of a Calcium-dependent Tyrosine Kinase in Vascular Smooth Muscle Cells by Angiotensin II and Platelet-derived Growth Factor

Neuritogenic Activity of Tetradecyl 2,3-Dihydroxybenzoate is Mediated Through the Insulin-Like Growth Factor 1 Receptor/Phosphatidylinositol 3 Kinase/Mitogen-Activated Protein Kinase Signaling Pathway

Neuronal Release of Probdnf

Recombinant Transforming Growth-Factor Type-Beta-3 - Biological-Activities And Receptor-Binding Properties In Isolated Bone-Cells

Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA.